Overview of Cannara's Upcoming Annual General Meeting
Cannara Biotech Inc., a notable player in the cannabis production industry, is set to hold its annual general meeting soon. With its operations centered on producing high-quality cannabis and derivative products, the company is keen to maintain transparency and communication with its shareholders. Their meeting, which is a significant event for stakeholders, is scheduled for an upcoming date in January 2025. This announcement has come amid unexpected postal service delays due to the ongoing nationwide postal strike in Canada, which began in mid-November 2024.
Proxy-Related Materials and Meeting Access
The Proxy-Related Materials for the meeting will be accessible via Cannara's official channels. This allows registered shareholders to review essential documentation ahead of the meeting, ensuring they are well-informed about the matters to be discussed. These materials will be available online, providing an alternative to traditional mail that may be affected by the postal disruptions.
Accessing Meeting Documents
Shareholders can conveniently access the Proxy-Related Materials through the Company's profile on SEDAR+ or directly on Cannara's investor section of their website. This move reflects Cannara's commitment to keeping its investors up-to-date despite external challenges.
Virtual Meeting Logistics
The upcoming meeting will be held in a virtual-only format. This ensures that all shareholders can participate from the comfort of their homes, regardless of the ongoing postal service issues. Interested parties can access the meeting via a live audio webcast and teleconference options. This digital approach not only aids in reaching a wider audience but also adheres to modern practices in corporate governance.
Agenda for the Annual General Meeting
Cannara’s annual general meeting will cover a range of critical agenda items that reflect the company's operations and future strategies. Specifically, shareholders will have the opportunity to evaluate and vote on several key resolutions:
- The election of directors who will serve until the next annual general meeting.
- The appointment of auditors for the fiscal year and the approval of their remuneration.
- Approval of amendments to the Company’s stock option plan and the restricted share unit compensation plan.
- Other essential business matters as may be deemed appropriate during the meeting.
These discussions are vital for shaping the direction of Cannara Biotech, particularly as it continues to establish itself in the cannabis market.
Impact of the Postal Strike on Communication
The Canadian postal strike has posed unique challenges for many corporations, including Cannara. The company is utilizing the CSA Coordinated Blanket Order 51-931, which grants exemptions concerning the delivery of proxy-related materials due to the strike. This order acknowledges the difficulties faced by shareholders and aims to ensure that they remain informed about their investments.
Steps Taken for Shareholder Assistance
Cannara encourages shareholders to access the materials online. Should shareholders need assistance, contacts are readily available through Cannara’s transfer agent. This proactive approach ensures that all shareholders can engage with the Company efficiently, with various options offered for those needing to request additional documentation or vote online.
About Cannara Biotech Inc.
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) stands as a vertically integrated producer of high-quality cannabis products. The Company operates two major facilities in a substantial area, allowing for impressive production capabilities while capitalizing on local resources to minimize operational costs. Cannara is committed to delivering premium products that meet the evolving needs of the cannabis market. As the country continues to navigate regulatory changes and public demands, Cannara remains dedicated to growth and innovation in the industry.
Contact Information
For any inquiries, shareholders can reach out directly to Cannara’s executive team. Nicholas Sosiak, the Chief Financial Officer, and Zohar Krivorot, the President & CEO, are available to address any questions regarding the upcoming meeting and company operations.
Frequently Asked Questions
What is the date of Cannara's annual general meeting?
The annual general meeting is scheduled for January 30, 2025.
How can shareholders access the proxy materials?
Shareholders can access the proxy materials through Cannara’s profile on SEDAR+ and the investors section of their website.
What should I do if I can't vote during the teleconference?
To vote, shareholders must join the meeting via the webcast, as teleconference participants won't have voting capabilities.
Who can I contact for assistance regarding voting?
Shareholders can reach out to Cannara’s transfer agent, Computershare Investor Services Inc., for help with voting and proxy materials.
What is Cannara's focus as a company?
Cannara focuses on producing premium-grade cannabis and cannabis derivatives while maintaining affordable pricing for Canadian markets.
